<DOC>
	<DOC>NCT00166517</DOC>
	<brief_summary>Immunogenicity and Safety of V260 in Healthy Infants in Korea</brief_summary>
	<brief_title>V260 Registration Study (V260-013)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>At first study vaccination, age 6 weeks through exactly 12 weeks History of congenital abdominal disorders, intussusception, or abdominal surgery History of known prior rotavirus disease Ongoing chronic diarrhea or failure to thrive Clinical evidence of active gastrointestinal illness</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Gastrointestinal Rotavirus</keyword>
</DOC>